From what I am seeing, they dont have much in the way of cash-on-hand. Even though their product sounds very interesting, how is it that they will continue forward?
The valuation of their company doesnt look to be much more then .05 cents a share if you divide their debt-adjusted assets value by their current outstanding shares (and this may not be the complete correct way to figure the liquidation value of the company)
I am considering investing in this one, but right now, dont feel comfortable paying more then .05 a share, so I will probably wait for a pull back if one is in the pipeline.
Be interesting to see what comes of this though, because Sepsis currently kills 1/3 of the people who contract it.
I looked at clinicaltrials.gov and found the clinical study being conducted with cytosorb and it appears it will be completed on Jan 2010. A little over 6 months off, so they have a while before any real info is released that would start a buzz about this stock.
Thats what I have found so far in the hour I spent looking at this one. Anything to add would be appreciated.
many thanks for your time/input. just came over from gnta board to take a look. will follow for now and do some dd. despite living down the street from this company ( as well as adxs), i'm trying not to invest because i'm sentimental! lol ! GLTY